Sumitomo Dainippon Pharma (4506, Reduce); strong Q1, but largely a function of one-off factors and Latuda, which has only 30 months of patent life left
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
